BioLineRX Ltd (BLRX) is a publicly traded Healthcare sector company. As of August 26, 2026, BLRX trades at $2.74 with a market cap of $13.10M and a P/E ratio of 0.00. BLRX moved -3.86% today. Year to date, BLRX is +1.79%; over the trailing twelve months it is -25.97%. Its 52-week range spans $2.15 to $14.70. Rallies surfaces BLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BioLineRX Ltd (BLRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BLRX moved -3.86% today.
| Metric | Value |
|---|---|
| Price | $2.74 |
| Market Cap | $13.10M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.70 |
| 52-Week Low | $2.15 |
| Volume | 2.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BLRX analyst coverage data. Average price target: $0.00.